19 results
8-K
EX-10.2
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
team with great confidence in your abilities to have a major impact on our mission and the special culture we are building.
Duties and Extent of Service
8-K
EX-99.4
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
to realize the benefit of such transactions if it is unable to successfully integrate them with its existing
operations and company culture. Any
424B3
e9osyx0m12r
28 Apr 23
Prospectus supplement
4:07pm
S-4/A
yp88v
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.32
c0gqdqt65coi e4
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.31
v7itr
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
DEF 14A
etsqpattkqcl498rrn3
27 Apr 22
Definitive proxy
4:04pm
424B4
uawank8v5x q0sd
5 Feb 21
Prospectus supplement with pricing info
5:12pm
DRS/A
6jbb wikn7ghkfr
15 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
ba441 vjf
13 May 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next